Figure 2

Structure and pharmacological effects of UA-4.
a, the structural formula of UA-4; b, dose-response of anti-proliferative effect of UA-4 on A-375, HepG2 and HELF cells; c, effects of UA-4 on cell cycle distribution in A-375 cells; d, effects of UA-4 on ΔΨm in A-375 cells. Results are expressed as percentage change in UA-4 treatment compared to the vehicle-treated control (*P < 0.05, **P < 0.01). e, A-375 cells were treated with UA-4 (1, 5, 10 μM) for 12 h and 24 h (f), respectively. Apoptosis was determined by Annxin-V-FITC/PI labeling. g, One step TUNEL apoptosis was tested on A-375 cells treated with UA-4 (1, 5, 10 μM) for 24 h.